Validic, a health IT company that developed an API to retrieve data from mobile health apps, wearables and medical devices, has been growing its clinical and wellness device company collaborations. The company, which is backed by Mark Cuban and other investors, has been successful in attracting companies to its collaboration pool, which has grown by 25 percent, according to an announcement the company made at Health Datapalooza this week.
It has recently added Omron, a Japanese electronics manufacturer which produces automated medical equipment such as blood pressure cuffs; Misfit Wearables, which develops activity trackers; and Polar, a manufacturer of activity tracking devices and heart-rate sensors using watches, wristbands and headbands. Its target customers are providers, pharmaceutical and wellness companies and insurers.
Although Validic has been talking to several pharma companies, the company couldn’t specify which ones. They would use the data retrieved from the apps and mobile devices in clinical trials and trial recruiting. Validic’s API would be especially useful for pharma companies. Data from apps and devices could reduce time to market for prescription clinical trials because the data is verified and trial participants may not have to come into the office for their progress to be assessed. It’s an especially important use case as the market continues to grow with FDA Class II medical devices.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
One of the health systems it counts as a customer is Kaiser Permanente. Generally speaking, hospitals are using its platform to make it easier to manage patients with chronic conditions, population health management and for patient engagement strategies.
